Radiopharmaceuticals for Relapsed or Refractory Ovarian Cancers

Overview of attention for article published in Frontiers in oncology, March 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 6,615 followers.

RT @FrontOncology: Radiopharmaceuticals for Relapsed or Refractory Ovarian Cancers: Charles A. Kunos, Jacek Capala, Shanda Finnigan, Gary L…

26 Jun 2019

Reply Repost Favourite

Radiopharmaceuticals for Relapsed or Refractory Ovarian Cancers: Charles A. Kunos, Jacek Capala, Shanda Finnigan, Gary L. Smith, Susan Percy Ivy https://t.co/4xlR88tKW2

26 Mar 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.